Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  1997-04-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/PNAS.94.8.4028PMID 9108099PMCID PMC20562
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diverse multidrug-resistance-modification agents inhibit cytolytic activity of natural killer cells

  2005cited by this paper
• Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine.

  1997cited by this paper
• Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo

  1996cited by this paper
• Substantial excretion of digoxin via the intestinal mucosa and prevention of long‐term digoxin accumulation in the brain by the mdrla P‐glycoprotein

  1996cited by this paper
• P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.

  1996cited by this paper
• Nonlinear pharmacokinetics of paclitaxel in mice results from the pharmaceutical vehicle Cremophor EL.

  1996cited by this paper
• What have we learnt thus far from mice with disrupted P-glycoprotein genes?

  1996cited by this paper
• Identification of a sister gene to P-glycoprotein.

  1995cited by this paper
• Modification of rhodamine staining allows identification of hematopoietic stem cells with preferential short-term or long-term bone marrow-repopulating ability.

  1995cited by this paper
• Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.

  1995cited by this paper
• Genetic analysis of the multidrug transporter.

  1995cited by this paper
• P-glycoprotein expression and function in circulating blood cells from normal volunteers.

  1994cited by this paper
• Drug excretion mediated by a new prototype of polyspecific transporter

  1994cited by this paper
• Extrusion of the P glycoprotein substrate rhodamine-123 distinguishes CD4 memory T cell subsets that differ in IL-2-driven IL-4 production.

  1994cited by this paper
• Heterogeneity in P‐glycoprotein (multidrug resistance) activity among murine peripheral T cells: Correlation with surface phenotype and effector function

  1994cited by this paper
• Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs.

  1994cited by this paper
• A mechanism for P-glycoprotein action in multidrug resistance: are we there yet?

  1994cited by this paper
• How cancer cells evade chemotherapy: sixteenth Richard and Hinda Rosenthal Foundation Award Lecture.

  1993cited by this paper
• Modulation of multidrug resistance: at the threshold.

  1993cited by this paper
• Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease.

  1993cited by this paper
• Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone.

  1992cited by this paper
• Rhodamine123 reveals heterogeneity within murine Lin-, Sca-1+ hemopoietic stem cells

  1992cited by this paper
• The role of the MDR1 (P-glycoprotein) gene in multidrug resistance in vitro and in vivo.

  1992cited by this paper
• Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype.

  1992cited by this paper
• Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells.

  1991cited by this paper
• Physical mapping, amplification, and overexpression of the mouse mdr gene family in multidrug-resistant cells

  1990cited by this paper
• Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities

  1990cited by this paper
• Pharmacology of drugs that alter multidrug resistance in cancer.

  1990cited by this paper
• Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.

  1989cited by this paper
• Differential overexpression of three mdr gene family members in multidrug-resistant J774.2 mouse cells. Evidence that distinct P-glycoprotein precursors are encoded by unique mdr genes.

  1989cited by this paper
• The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues

  1989cited by this paper
• Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.

  1989cited by this paper
• The biochemistry of P-glycoprotein-mediated multidrug resistance.

  1989cited by this paper
• The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus.

  1988cited by this paper
• Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.

  1987cited by this paper
• Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells.

  1986cited by this paper
• Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins.

  1986cited by this paper
• The activity of natural cytotoxic cells is augmented by interleukin 2 and interleukin 3

  1983cited by this paper
• Establishment of human T lymphocyte clones highly cytotoxic for an EBV-transformed B cell line in serum-free medium: isolation of clones that differ in phenotype and specificity.

  1982cited by this paper
• Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil.

  1981cited by this paper

• Changed expression of placental transporters and disrupted epigenetic patterns in a rat model of schizophrenia

  2025cites this paper
• 20 years of taxane therapy in prostate cancer - the past, present and future.

  2025cites this paper
• Glucosamine activates intestinal P-glycoprotein inhibiting drug absorption

  2025cites this paper
• Functional Characterization of the Cat and Dog Wild-Type and Mutant MDR1 Carrier Proteins and Frequency of the MDR1 Gene Mutation in 800 Cats From Germany.

  2025cites this paper
• Multidrug Resistance: Are We Still Afraid of the Big Bad Wolf

  2025cites this paper
• Pharmacogenetic Biomarkers of Ibrutinib Response and Toxicity in Chronic Lymphocytic Leukemia: Insights from an Observational Study

  2025cites this paper
• Novel screening approach for stem cell selective inhibitors and their possible translational therapeutic potential for endometriosis.

  2025cites this paper
• Prediction of drug-drug interaction risk of P-glycoprotein substrate in drug discovery.

  2024cites this paper
• Exploring bat-inspired cyclic tryptophan diketopiperazines as ABCB1 Inhibitors

  2024cites this paper
• Multidrug resistance Gene-1 polymorphisms (C3435T and G2677T) and the risk of inflammatory bowel disease in Egyptian patients.

  2024cites this paper
• Non-Nutritive Sweeteners Acesulfame Potassium and Sucralose Are Competitive Inhibitors of the Human P-glycoprotein/Multidrug Resistance Protein 1 (PGP/MDR1)

  2023cites this paper
• P-glycoprotein (MDR1/ABCB1) Restricts Brain Penetration of the Main Active Heroin Metabolites 6-monoacetylmorphine (6-MAM) and Morphine in Mice

  2023cites this paper
• Nanoplatform-based cellular reactive oxygen species regulation for enhanced oncotherapy and tumor resistance alleviation

  2023cites this paper
• Novel function of U7 snRNA in the repression of HERV1/LTR12s and lincRNAs in human cells

  2023cites this paper
• Functional Evaluation of P-gp and Bcrp at the Murine Blood-Cerebrospinal Fluid Barrier

  2023cites this paper
• Metabolomic Profiling and Drug Interaction Characterization Reveal Riboflavin As a Breast Cancer Resistance Protein–Specific Endogenous Biomarker That Demonstrates Prediction of Transporter Activity In Vivo

  2023cites this paper
• Differential Expression of ABC Transporter Genes in Brain Vessels vs. Peripheral Tissues and Vessels from Human, Mouse and Rat

  2023cites this paper
• Limited Impact of Murine Placental MDR1 on Fetal Exposure of Certain Drugs Explained by Bypass Transfer Between Adjacent Syncytiotrophoblast Layers

  2022cites this paper
• Murine Central Nervous System and Bone Marrow Distribution of the Aurora A Kinase Inhibitor Alisertib: Pharmacokinetics and Exposure at the Sites of Efficacy and Toxicity

  2022cites this paper
• Cardiac glycoside-mediated turnover of Na, K-ATPases as a rational approach to reducing cell surface levels of the cellular prion protein

  2022cites this paper
• Lactobacillus acidophilus BIOTECH 1900 decreases the transepithelial mucosal-to-serosal transport of colchicine in an ex vivo non-everted gut sac model.

  2022cites this paper
• Differential ABC transporter expression during hematopoiesis contributes to neutrophil-biased toxicity of Aurora kinase inhibitors

  2022cites this paper
• Implication of ABC transporters in non-proliferative diseases.

  2022cites this paper
• Comparing the Secretomes of Chemorefractory and Chemoresistant Ovarian Cancer Cell Populations

  2022cites this paper
• Ivermectin: Evaluation of Efficacy and Safety in COVID-19

  2022cites this paper
• Current development of cabazitaxel drug delivery systems.

  2022cites this paper
• and does

  2022cites this paper
• Investigating Key Targets of Dajianzhong Decoction for Treating Crohn’s Disease Using Weighted Gene Co-Expression Network

  2022cites this paper
• P-Glycoprotein (MDR1/ABCB1) Restricts Brain Accumulation of the Novel EGFR Inhibitor EAI045 and Oral Elacridar Coadministration Enhances Its Brain Accumulation and Oral Exposure

  2022cites this paper
• Identification of NVP-CLR457 as an Orally Bioavailable Non-CNS-Penetrant pan-Class IA Phosphoinositol-3-Kinase Inhibitor.

  2022cites this paper
• Ether lipid transfer across the blood-brain and placental barriers does not improve by inactivation of the most abundant ABC transporters.

  2022cites this paper
• Chemoresistance in female-specific cancers and the associated anti-resistance therapies

  2021cites this paper
• The roles of the human ATP-binding cassette transporters P-glycoprotein and ABCG2 in multidrug resistance in cancer and at endogenous sites: future opportunities for structure-based drug design of inhibitors

  2021cites this paper
• Phenotypic Consequences of SLC25A40-ABCB1 Fusions beyond Drug Resistance in High-Grade Serous Ovarian Cancer

  2021cites this paper
• Mechanistic Computational Models of Epithelial Cell Transporters-the Adorned Heroes of Pharmacokinetics

  2021cites this paper
• Preclinical studies for plant-based oral enzyme replacement therapy (Oral-ERT) in Pompe disease knockout mice with transgenic tobacco seeds expressing human GAA (tobrhGAA)

  2021cites this paper
• ABCB1 and ABCG2 limit brain penetration and, together with CYP3A4, total plasma exposure of abemaciclib and its active metabolites.

  2021cites this paper
• Paclitaxel-Based Chemotherapy Targeting Cancer Stem Cells from Mono- to Combination Therapy

  2021cites this paper
• LncRNA as a multifunctional regulator in cancer multi-drug resistance

  2021cites this paper
• Functional role and regulation of permeability‐glycoprotein (P‐gp) in the fetal membrane during drug transportation

  2021cites this paper
• PARP Inhibitors and Myeloid Neoplasms: A Double-Edged Sword

  2021cites this paper
• P-Glycoprotein (ABCB1/MDR1) Controls Brain Penetration and Intestinal Disposition of the PARP1/2 Inhibitor Niraparib.

  2021cites this paper
• Taxanes in cancer treatment: Activity, chemoresistance and its overcoming.

  2021cites this paper
• The role of drug efflux and uptake transporters ABCB1 (P-gp), ABCG2 (BCRP) and OATP1A/1B and of CYP3A4 in the pharmacokinetics of the CDK inhibitor milciclib.

  2021cites this paper
• Potential use of ivermectin for the treatment and prophylaxis of SARS-CoV-2 infection

  2021cites this paper
• Species difference in brain penetration of P-gp and BCRP substrates among monkey, dog and mouse.

  2021cites this paper
• The Interplay of ABC Transporters in Aβ Translocation and Cholesterol Metabolism: Implicating Their Roles in Alzheimer’s Disease

  2020cites this paper
• Mechanisms of Taxane Resistance

  2020influential citation
• аспекты эффективности тразодоном the efficacy and safety of trazodone therapy

  2020cites this paper
• ABC Transporters: An Overlooked Mechanism of Drug Failure in Our Preclinical Models?

  2020cites this paper
• P-glycoprotein Expression Is Upregulated in a Pre-Clinical Model of Traumatic Brain Injury

  2020cites this paper
• Circadian Pharmacokinetics

  2020cites this paper
• Looking back at multidrug resistance (MDR) research and ten mistakes to be avoided when writing about ABC transporters in MDR

  2020cites this paper
• Bevacizumab and Sorafenib Modulate P-Glycoprotein Function In Vitro and Bevacizumab Increases In Vivo Sorafenib Plasma Concentrations in Mice

  2020cites this paper
• Genome-wide analysis of ATP-binding cassette transporters sheds light on the genes related to bioactive metabolite transportation in Salvia miltiorrhiza

  2020cites this paper
• Epigenetic Regulation of MDR1 and BCRP Transporters by HDAC Inhibition

  2020cites this paper
• Efflux transporters in cancer resistance: Molecular and functional characterization of P-glycoprotein

  2020cites this paper
• Identification of a lathyrane-type diterpenoid EM-E-11-4 as a novel paclitaxel resistance reversing agent with multiple mechanisms of action

  2020cites this paper
• Kidney-on-a-chip

  2020cites this paper
• Application of genetically modified rodent models in drug discovery and development for translation of clinical ADME properties

  2020cites this paper
• Physiological expression and function of the MDR1 transporter in cytotoxic T lymphocytes

  2020influential citation
• Epigenetic Regulation of MDR1 and BCRP Transporters by HDAC Inhibition.

  2020cites this paper
• Basic Neurobiology Techniques

  2020cites this paper
• Donepezil, a cholinesterase inhibitor used in Alzheimer's disease therapy, is actively exported out of the brain by abcb1ab p-glycoproteins in mice.

  2020cites this paper
• Role of endoplasmic reticulum stress in size-dependent inhibition of P-glycoprotein by silver nanoparticles in multidrug-resistant breast cancer cells

  2020cites this paper
• Circadian Clock and Efflux Transporters

  2020cites this paper
• Development and validation of a sensitive UHPLC-MS/MS analytical method for venetoclax in mouse plasma, and its application to pharmacokinetic studies.

  2020cites this paper
• Brain accumulation of tivozanib is restricted by ABCB1 (P-glycoprotein) and ABCG2 (breast cancer resistance protein) in mice.

  2020cites this paper
• ABC Transporter-Mediated Multidrug-Resistant Cancer.

  2019cites this paper
• Current Research Method in Transporter Study.

  2019cites this paper
• Long-Term Combinatorial Exposure to Trichloroethylene and Inorganic Arsenic in Genetically Heterogeneous Mice Results in Renal Tubular Damage and Cancer-Associated Molecular Changes

  2019cites this paper
• A Y1 receptor ligand synergized with a P-glycoprotein inhibitor improves the therapeutic efficacy of multidrug resistant breast cancer.

  2019cites this paper
• ABCB1 protects bat cells from DNA damage induced by genotoxic compounds

  2019cites this paper
• Impact of reduced P‐glycoprotein function on digoxin concentrations in patients with dementia

  2019cites this paper
• Brain accumulation of osimertinib and its active metabolite AZ5104 is restricted by ABCB1 (P-glycoprotein) and ABCG2 (breast cancer resistance protein).

  2019cites this paper
• Harnessing Hematopoietic Stem Cell Low Intracellular Calcium Improves Their Maintenance In Vitro.

  2019cites this paper
• P-glycoprotein (MDR1/ABCB1) and Breast Cancer Resistance Protein (BCRP/ABCG2) limit brain accumulation of the FLT3 inhibitor quizartinib in mice.

  2019cites this paper
• P-glycoprotein limits ribociclib brain exposure and CYP3A4 restricts its oral bioavailability.

  2019cites this paper
• Using Zebrafish to Study and Visualize Barriers of the CNS

  2019cites this paper
• A novel chitosan-based nanomedicine for multi-drug resistant breast cancer therapy

  2019cites this paper
• Paclitaxel loaded EDC-crosslinked fibroin nanoparticles: a potential approach for colon cancer treatment

  2019cites this paper
• Structure-Activity Relationships of Efflux Transporter Inhibitors

  2019cites this paper
• Reversal of P-Glycoprotein and Breast Cancer Resistance Protein Mediated Multidrug Resistance In Vitro Using In Silico Identified Novel Compounds

  2019cites this paper
• Improved Brain Penetration and Antitumor Efficacy of Temozolomide by Inhibition of ABCB1 and ABCG21

  2018cites this paper
• An in vitro method for nephrotoxicity evaluation using HK-2 human kidney epithelial cells combined with biomarkers of nephrotoxicity.

  2018cites this paper
• Genomics and Drug Transporters and Application in Drug Discovery, Delivery, and Development

  2018cites this paper
• Effect of Polymorphisms on the Pharmacokinetics, Pharmacodynamics and Safety of Sertraline in Healthy Volunteers

  2018cites this paper
• Different structures of berberine and five other protoberberine alkaloids that affect P-glycoprotein-mediated efflux capacity

  2018cites this paper
• Mechanisms and the clinical relevance of complex drug–drug interactions

  2018cites this paper
• Interplay between P-Glycoprotein Expression and Resistance to Endoplasmic Reticulum Stressors

  2018cites this paper
• The Placental Barrier: the Gate and the Fate in Drug Distribution

  2018cites this paper
• Intrinsic Xenobiotic Resistance of the Intestinal Stem Cell Niche.

  2018cites this paper
• Molecular Biology of ABC Transporters

  2018cites this paper
• Development and Characterization of MDR1 (Mdr1a/b) CRISPR/Cas9 Knockout Rat Model

  2018cites this paper
• Effect of ABCB1 C3435T Polymorphism on Pharmacokinetics of Antipsychotics and Antidepressants

  2018cites this paper
• Safe Use of Epidural Corticosteroid Injections: Recommendations of the WIP Benelux Work Group

  2018cites this paper
• Avermectin toxicity in bovines less than thirty days old.

  2018cites this paper
• P-Glycoprotein (MDR1/ABCB1) Restricts Brain Penetration of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib, While Cytochrome P450-3A (CYP3A) Limits Its Oral Bioavailability.

  2018cites this paper
• Characterization of P-Glycoprotein Humanized Mice Generated by Chromosome Engineering Technology: Its Utility for Prediction of Drug Distribution to the Brain in Humans

  2018cites this paper
• A CRISPR-Cas9 Generated MDCK Cell Line Expressing Human MDR1 Without Endogenous Canine MDR1 (cABCB1): An Improved Tool for Drug Efflux Studies.

  2017cites this paper